Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence
Author:
Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology
Link
https://link.springer.com/content/pdf/10.1007/s40674-021-00182-1.pdf
Reference70 articles.
1. Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018;17(9):816–28. https://doi.org/10.1016/S1474-4422(18)30254-0.
2. Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A. Myositis autoantibodies and clinical phenotypes. Auto Immun Highlights. 2014;5(3):69–75. https://doi.org/10.1007/s13317-014-0060-4.
3. Zong M, Lundberg IE. Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol. 2011;7(5):297–306. https://doi.org/10.1038/nrrheum.2011.39.
4. Lahoria R, Selcen D, Engel AG. Microvascular alterations and the role of complement in dermatomyositis. Brain. 2016;139(Pt 7):1891–903. https://doi.org/10.1093/brain/aww122.
5. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60(7):2193–200. https://doi.org/10.1002/art.24621.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Les inhibiteurs de JAK en médecine interne;La Revue de Médecine Interne;2024-06
2. Dermatomyositis, Antisynthetase-Syndrom und immunvermittelte nekrotisierende Myopathie;Aktuelle Rheumatologie;2024-06
3. A case of refractory amyopathic dermatomyositis successfully treated with upadacitinib;International Journal of Dermatology;2024-03-20
4. JAK inhibitors and black box warnings: what is the future for JAK inhibitors?;Expert Review of Clinical Immunology;2023-09-04
5. Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis;Clinical Reviews in Allergy & Immunology;2022-02-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3